Cargando…

Feasibility trial for the management of severe acute malnutrition in older children with sickle cell anemia in Nigeria

Children with sickle cell anemia (SCA) living in Nigeria are at an increased risk of malnutrition, which contributes to increased morbidity and mortality. However, evidence-based guidelines for managing malnutrition in children with SCA are lacking. To address this gap, we conducted a multicenter, r...

Descripción completa

Detalles Bibliográficos
Autores principales:	Abdullahi, Shehu U., Gambo, Safiya, Murtala, Hassan Adam, Kabir, Halima, Shamsu, Khadija A., Gwarzo, Garba, Acra, Sari, Stallings, Virginia A., Rodeghier, Mark, DeBaun, Michael R., Klein, Lauren J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The American Society of Hematology 2023
Materias:	Clinical Trials and Observations
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10582275/ https://www.ncbi.nlm.nih.gov/pubmed/37428866 http://dx.doi.org/10.1182/bloodadvances.2023010789

Ejemplares similares

Risk factors in underweight older children with sickle cell anemia: a comparison of low- to high-income countries
por: Klein, Lauren Jane, et al.
Publicado: (2023)

Underweight children older than 5 years with sickle cell anemia are at risk for early mortality in a low-resource setting
por: Klein, Lauren J., et al.
Publicado: (2022)

Hydroxyurea for secondary stroke prevention in children with sickle cell anemia in Nigeria: a randomized controlled trial
por: Abdullahi, Shehu U., et al.
Publicado: (2023)

World Health Organization’s Growth Reference Overestimates the Prevalence of Severe Malnutrition in Children with Sickle Cell Anemia in Africa
por: Ghafuri, Djamila L., et al.
Publicado: (2020)

Economic evaluation of regular transfusions for cerebral infarct recurrence in the Silent Cerebral Infarct Transfusion Trial
por: Hsu, Peter, et al.
Publicado: (2021)

Decreased parasite burden and altered host response in children with sickle cell anemia and severe anemia with malaria
por: Henrici, Ryan C., et al.
Publicado: (2021)

Longitudinal analysis of cardiac abnormalities in pediatric patients with sickle cell anemia and effect of hydroxyurea therapy
por: Dhar, Arushi, et al.
Publicado: (2021)

Longitudinal study of glomerular hyperfiltration in adults with sickle cell anemia: a multicenter pooled analysis
por: Ataga, Kenneth I., et al.
Publicado: (2022)

High mortality from Plasmodium falciparum malaria in children living with sickle cell anemia on the coast of Kenya
por: McAuley, Charlotte F., et al.
Publicado: (2010)

Incidence and predictors of priapism events in sickle cell anemia: a diary-based analysis
por: Idris, Ibrahim M., et al.
Publicado: (2022)

Zinc for infection prevention in children with sickle cell anemia: a randomized double-blind placebo-controlled trial
por: Namazzi, Ruth, et al.
Publicado: (2023)

Deferiprone for transfusional iron overload in sickle cell disease and other anemias: open-label study of up to 3 years
por: Elalfy, Mohsen S., et al.
Publicado: (2022)

A feasibility randomized controlled trial of an mHealth app vs booklets for patient-facing guidelines in adults with SCD
por: Cronin, Robert M., et al.
Publicado: (2023)

Improved Guideline Adherence With Integrated Sickle Cell Disease and Asthma Care
por: McClain, Brandi L., et al.
Publicado: (2016)

Creating an automated contemporaneous cohort in sickle cell anemia to predict survival after disease-modifying therapy
por: Cronin, Robert M., et al.
Publicado: (2022)

Annual decline in lung function in adults with sickle cell disease is similar to that observed in adults with cystic fibrosis
por: Hodges, Brock, et al.
Publicado: (2022)

Primary Prevention of Stroke in Children With Sickle Cell Anemia in Nigeria: Protocol for a Mixed Methods Implementation Study in a Community Hospital
por: Bello-Manga, Halima, et al.
Publicado: (2022)

Establishing Sickle Cell Disease Stroke Prevention Teams in Africa is Feasible: Program Evaluation Using the RE-AIM Framework
por: Ghafuri, Djamila L., et al.
Publicado: (2022)

Pharmacokinetics, pharmacodynamics, safety, and efficacy of crizanlizumab in patients with sickle cell disease
por: Kanter, Julie, et al.
Publicado: (2022)

Epidemiology of Maternal Nutritional Status and Risk of Adverse Birth Outcomes in Undernourished Mothers with Sickle Cell Disease: A Systematic Review and Meta-Analysis Protocol
por: Klein, Lauren J., et al.
Publicado: (2023)

Clinical predictors of poor outcomes in patients with sickle cell disease and COVID-19 infection
por: Minniti, Caterina P., et al.
Publicado: (2021)

Pneumococcal infections in children with sickle cell disease before and after pneumococcal conjugate vaccines
por: Adamkiewicz, Thomas V., et al.
Publicado: (2023)

Metformin for treatment of cytopenias in children and young adults with Fanconi anemia
por: Pollard, Jessica A., et al.
Publicado: (2022)

Comorbidities are risk factors for hospitalization and serious COVID-19 illness in children and adults with sickle cell disease
por: Mucalo, Lana, et al.
Publicado: (2021)

Long-term survival with sickle cell disease: a nationwide cohort study of Medicare and Medicaid beneficiaries
por: Jiao, Boshen, et al.
Publicado: (2023)

Ticagrelor vs placebo for the reduction of vaso-occlusive crises in pediatric sickle cell disease: the HESTIA3 study
por: Heeney, Matthew M., et al.
Publicado: (2022)

Early diagnosis of sickle cell disease at birth hospitals and vaccination centers in Angola using point-of-care tests
por: Olaniyan, Halimat S., et al.
Publicado: (2023)

Pacritinib is a potent ACVR1 inhibitor with significant anemia benefit in patients with myelofibrosis
por: Oh, Stephen T., et al.
Publicado: (2023)

C1-inhibitor treatment in patients with severe complement-mediated autoimmune hemolytic anemia
por: de Boer, Esther C. W., et al.
Publicado: (2023)

Altered VWF:ADAMTS13 homeostasis is a target for therapeutic intervention in sickle cell disease
por: Chaturvedi, Shruti, et al.
Publicado: (2022)

Safety and immunogenicity of V114, a 15-valent pneumococcal conjugate vaccine, in children with SCD: a V114-023 (PNEU-SICKLE) study
por: Quinn, Charles T., et al.
Publicado: (2022)

Deferiprone vs deferoxamine for transfusional iron overload in SCD and other anemias: a randomized, open-label noninferiority study
por: Kwiatkowski, Janet L., et al.
Publicado: (2022)

Sexual violence as a precipitator of chronic pain in young adults with sickle cell disease
por: Chopra, Maya, et al.
Publicado: (2022)

Silent infarction in sickle cell disease is associated with brain volume loss in excess of infarct volume
por: Jones, R. Sky, et al.
Publicado: (2023)

Vaso-Occlusive Pain and Menstruation in Sickle Cell Disease: A Focus Group Analysis
por: Day, Melissa, et al.
Publicado: (2020)

Barriers and Facilitators to a Task-Shifted Stroke Prevention Program for Children with Sickle Cell Anemia in a Community Hospital: A Qualitative Study
por: Bello-Manga, Halima, et al.
Publicado: (2023)

2484: Establishment of the Tennessee-sickle cell disease network as a mechanism for engaging a rare disease population in patient centered outcomes research
por: Mayo-Gamble, Tilicia, et al.
Publicado: (2018)

The Sickle Cell Pro-Inflammatory Response to Interval Testing Study (SPRINTS) in children and young adults with sickle cell anemia – Study design and methodological strategies
por: Liem, R.I., et al.
Publicado: (2020)

Sickle Cell Disease Clinical Trials and Phenotypes
por: Ezekekwu, Chinedu A, et al.
Publicado: (2018)

Translating research to usual care of children with sickle cell disease in Northern Nigeria: lessons learned from the SPRING Trial Team
por: Bello-Manga, Halima, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_t4diqfd20t8k7s1a27k6729b77